These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1155 related articles for article (PubMed ID: 10335528)
1. [Prevention of joint damage in hemophilic children with early prophylaxis]. Kreuz W; Escuriola Ettingshausen C; Funk M; Pons S; Schmidt H; Kornhuber B Orthopade; 1999 Apr; 28(4):341-6. PubMed ID: 10335528 [TBL] [Abstract][Full Text] [Related]
2. Prevention of joint damage in hemophilic children with early prophylaxis. Kreuz W; Escuriola Ettingshausen C; Funk M; Pons S; Schmidt H; Kornhuber B Orthopade; 1999 Apr; 28(4):341-346. PubMed ID: 28246905 [TBL] [Abstract][Full Text] [Related]
3. When should prophylactic treatment in patients with haemophilia A and B start?--The German experience. Kreuz W; Escuriola-Ettingshausen C; Funk M; Schmidt H; Kornhuber B Haemophilia; 1998 Jul; 4(4):413-7. PubMed ID: 9873763 [TBL] [Abstract][Full Text] [Related]
4. Orthopaedic evaluation in children with severe haemophilia A or B submitted to primary prophylaxis therapy in a coagulopathy treatment centre. De Podestá Haje D; Ono F; De Oliveira GB; Almeida J; De Paula JC; Batista Neto LV; Silva Barros SB Haemophilia; 2011 Mar; 17(2):228-32. PubMed ID: 21070500 [TBL] [Abstract][Full Text] [Related]
5. Haemophilia prophylaxis in young patients--a long-term follow-up. Löfqvist T; Nilsson IM; Berntorp E; Pettersson H J Intern Med; 1997 May; 241(5):395-400. PubMed ID: 9183307 [TBL] [Abstract][Full Text] [Related]
6. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. Nilsson IM; Berntorp E; Löfqvist T; Pettersson H J Intern Med; 1992 Jul; 232(1):25-32. PubMed ID: 1640190 [TBL] [Abstract][Full Text] [Related]
7. Radiological and orthopedic score in pediatric hemophilic patients with early and late prophylaxis. Funk M; Schmidt H; Escuriola-Ettingshausen C; Pons S; Dzinaj T; Weimer C; Kornhuber B; Kreuz W Ann Hematol; 1998 Oct; 77(4):171-4. PubMed ID: 9829849 [TBL] [Abstract][Full Text] [Related]
8. Identification and long-term observation of early joint damage by magnetic resonance imaging in clinically asymptomatic joints in patients with haemophilia A or B despite prophylaxis. Olivieri M; Kurnik K; Pfluger T; Bidlingmaier C Haemophilia; 2012 May; 18(3):369-74. PubMed ID: 22032268 [TBL] [Abstract][Full Text] [Related]
9. Radiologic evaluation of prophylaxis in severe haemophilia. Pettersson H; Nilsson IM; Hedner U; Noréhn K; Ahlberg A Acta Paediatr Scand; 1981 Jul; 70(4):565-70. PubMed ID: 6797235 [TBL] [Abstract][Full Text] [Related]
10. [Prophylactic treatment with clotting factor to prevent joint damage in patients with severe haemophilia: costs versus benefits]. Roosendaal G; Lafeber FP Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2606-8. PubMed ID: 18161260 [TBL] [Abstract][Full Text] [Related]
11. Low dose secondary prophylaxis reduces joint bleeding in severe and moderate haemophilic children: a pilot study in China. Wu R; Luke KH; Poon MC; Wu X; Zhang N; Zhao L; Su Y; Zhang J Haemophilia; 2011 Jan; 17(1):70-4. PubMed ID: 20579111 [TBL] [Abstract][Full Text] [Related]
12. The overall effectiveness of prophylaxis in severe haemophilia. Panicker J; Warrier I; Thomas R; Lusher JM Haemophilia; 2003 May; 9(3):272-8. PubMed ID: 12694517 [TBL] [Abstract][Full Text] [Related]
13. Forum on: the role of recombinant factor VIII in children with severe haemophilia A. Franchini M; Coppola A; Molinari AC; Santoro C; Schinco P; Speciale V; Tagliaferri A Haemophilia; 2009 Mar; 15(2):578-86. PubMed ID: 19187188 [TBL] [Abstract][Full Text] [Related]
14. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B. Iorio A; Marchesini E; Marcucci M; Stobart K; Chan AK Cochrane Database Syst Rev; 2011 Sep; (9):CD003429. PubMed ID: 21901684 [TBL] [Abstract][Full Text] [Related]
15. Lifelong prophylaxis in a large cohort of adult patients with severe haemophilia: a beneficial effect on orthopaedic outcome and quality of life. Khawaji M; Astermark J; Berntorp E Eur J Haematol; 2012 Apr; 88(4):329-35. PubMed ID: 22221195 [TBL] [Abstract][Full Text] [Related]
16. Is on-demand treatment effective in patients with severe haemophilia? Aznar JA; Marco A; Jiménez-Yuste V; Fernández-Fontecha E; Pérez R; Soto I; Parra R; Moreno M; Mingot ME; Moret A; Haemophilia; 2012 Sep; 18(5):738-42. PubMed ID: 22537601 [TBL] [Abstract][Full Text] [Related]
17. Progression of haemophilic arthropathy in children: a Lithuanian--Danish comparative study. Saulyte Trakymiene S; Clausen N; Poulsen LH; Ingerslev J; Rageliene L Haemophilia; 2013 Mar; 19(2):212-8. PubMed ID: 23167920 [TBL] [Abstract][Full Text] [Related]
18. Utility of the Haemophilia Joint Health Score in study of episodically treated boys with severe haemophilia A and B in Lithuania. Saulyte Trakymiene S; Ingerslev J; Rageliene L Haemophilia; 2010 May; 16(3):479-86. PubMed ID: 20070384 [TBL] [Abstract][Full Text] [Related]
19. Effects of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe haemophilia A. Results of a multicenter non-concurrent cohort study. Schobess R; Kurnik K; Friedrichs F; Halimeh S; Krümpel A; Bidlingmaier C; Nowak-Göttl U Thromb Haemost; 2008 Jan; 99(1):71-6. PubMed ID: 18217137 [TBL] [Abstract][Full Text] [Related]
20. Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors. Fischer K; Valentino L; Ljung R; Blanchette V Haemophilia; 2008 Jul; 14 Suppl 3():196-201. PubMed ID: 18510542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]